The role of the basic-fibroblast growth factor (b-FGF) in cylosporine-induced nephrotoxicity

In Vivo

Volumn 20, Issue 2, 2006, Pages 265-270

  Efthimiadou, Anna ^a   Lambropoulou, M ^a   Pagonopoulou, O ^a   Vakalopoulous, I ^a   Papadopoulous, N ^a   Nikolettos, N ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Angiogenesis; B fibroblast growth; Cyclosporine; Nephrotoxicity

Indexed keywords

CD31 ANTIGEN; CREATININE; CYCLOSPORIN A; EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY; NITROGEN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; UREA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY BLOOD VESSEL; KIDNEY FIBROSIS; MALE; NEPHROTOXICITY; NONHUMAN; RAT; RENAL PROTECTION; TREATMENT OUTCOME;

EID: 33645785878     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Goldfarb M: Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev 7: 311-325, 1996.
2. Nishimura T, Nakatake Y, Konishi M and Itoh N: Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta 1492: 203-206, 2000.
3. Baird A and Bohlen P: Fibroblast growth factors. In: Peptide Growth Factors and Their Receptors. Handbook of Experimental Pharmacology Sporn MB, Roberts AB (eds.), Berlin, Springer-Verlag, pp. 369-418, 1990.
4. Myers RL, Payson R.A., Chotani MA, Deaven LL and Chiu IM: Gene structure and differential expression of acidic fibroblast growth factor mRNA: identification and distribution of four different transcripts. Oncogene 8: 341-349, 1993.
5. Floege J, Hudkins KL, Eitner F, Cui Y, Morrison RS, Scheiling MA and Alpers CE: Localization of fibroblast growth factor-2 (basic FGF) and FGF receptor-1 in adult human kidney. Kidney Int 56: 883-897, 1999.
6. Cauchi J, Alcorn D, Cancilia B, Key B, Berka JL, Nurcombe V, Ryan GB and Bertram JF: Light-microscopic immunolocalization of fibroblast growth factor-1 and -2 in adult rat kidney. Cell Tissue Res 285: 179-187, 1996.
7. Kahan BD: Cyclosporine: the agent and its actions. Transplant Proc 17: 5-18, 1985.
8. Sulivan BA, Hak LJ and Finn WF: Cyclosporine nephrotoxicity: studies in laboratory animals. Transplant Proc 17: 145-154, 1985.
9. Coffman TM, Carr DR, Yarger WE and Klotman PE: Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity. Transplantation 43: 282-285, 1987.
10. Moutabarrid A, Ishibashi M, Fukunaga M, Kameoka H, Takano Y, Kokado Y et al: FK506 mechanism of nephrotoxicity: stimulatory effect on endothelin secretion by cultured kidney cells and tubular cell toxicity in vitro. Transplant Proc 23: 3133-3136, 1991.
11. Nakahama H: Stimulatory effect of cyclosporine A on endothelin secretion by a cultured renal epithelial cell line, LLC-PKI cells. Eur J Pharmacol 180: 191-192, 1990.
12. Mihatsch MJ, Thiel G and Ryffel B: Morphologic diagnosis of cyclosporine nephrotoxicity. Semin Diagn Pathol 5: 104-121, 1988.
13. Shibab FS, Bennett WM, Yi H, Choi SO and Anhoh TF: Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosrine nephrotoxicity. Kidney Int 65(4): 1262-1271, 2004.
14. Candilla B, Davis A, Cauchy JA, Risbridger P and Bertam JF: FGF receptors and their ligands in the adult rat kidney. Kidney Int 60(1): 147-155, 2001.
15. Ford MD, Cauchi J, Greferath U and Bertram JF: Expression of fibroblast growth factors and their receptors in rat glomeruli. Kidney Int 51(6): 1729-1738, 1997.
16. Efthimiadou A, Asimakopoulos B, Nikolettos N, Giatromanolaki A, Sivridis E, Lialiaris TS, Papachristou D and Kontoleon E: The angiogenetic effect of intramuscular administration of VEGF on muscle. The influence of exercise on angiogenesis. In Vivo 18: 825-830, 2004.
17. Schrijvers BF, Flyvbjerg A and De Vriese AS: The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int, 65, pp. 2003-2017, 2004.
18. Hernandeza GL, Volperb OV, Inigueza MA, Lorenzoa E, Martinez-Martineza S, Graua R, Fresnoa M and Redondoa JM: Selective inhibition of VEGF-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cycloxygenase 2. J Exp Med 193(5): 607-620, 2001.
19. Shihab FS, Bennett WM, Isaac J, Yi H and Andoh TF: Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity. Kidney Int 62(2): 422-433, 2002.
20. Du A and Zou W: The role of b-FGF in renal tubular injury and the interstitial lesion. Zhonghua Bing Li Xue Za Zhi 29(3): 208-211, 2000.
21. Yang CW, Lee SH, Jim SW, Jung JY, Kim HW, Choi BS, Cha JH, Kim J and Bang BK: Cyclosporine or FK506 decrease mature epidermal growth factor protein expresssion and renal tubular regeneration in rat kidney with ischemia/reperfusion injury. Nephron 92(4): 914-921, 2002.
22. Messmer UK, Briner VA and Pfeilschifter J: Basic fibroblast growth factor selectively enhances TNF-alpha-induced apoptotic cell death in glomerular endothelial cells: effects on apoptotic signaling pathways. J Am Soc Nephrol 11(12): 2199-2211, 2000.
23. Floege J, Burg M, Hugo C, Gordon KL, Van Goor H, Reidy M, Couser WG, Koch KM and Johnson RJ: Endogenous flbroblast growth factor-2 mediates cytotoxicity in experimental mesangioproliferative glomerulonephritis. J Am Soc Nephrol 9(5): 792-801, 1998.
24. Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Muller GA and Neilson EG: Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 61(5): 1714-1728, 2002.